Ubiquinol in Parkinson's Disease: Safety, Tolerability, and Effects Upon Oxidative Damage and Mitochondrial Biomarkers
Clinical trial NCT03061513 · COMPLETED
Trial details
- NCT number
- NCT03061513
- Sponsor
- Weill Medical College of Cornell University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-28
- Primary completion
- 2016-12-31
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.